Quest Diagnostics Inc (DGX)-Medical Equipment-Deals and Alliances Profile

Quest Diagnostics Inc (DGX)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME40157D
  • |
  • Pages: 99
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology. It also provides diagnostic products. The company offers these services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. The company is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9

Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11

Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12

Quest Diagnostics Inc, Medical Equipment, Deal Details 15

Venture Financing 15

Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 15

Partnerships 15

Vermillion Enters into Licensing Agreement with Quest Diagnostics 15

Clinical Genomics Enters into Licensing Agreement with CSIRO 16

Illumina Enters Into Licensing Agreement With Quest Diagnostics 17

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 18

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 18

Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 19

Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 20

Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 21

Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 22

Biocept to Form Partnership with Quest Diagnostics Mexico 22

DermTech Enters into Agreement with Dermpath Diagnostics 23

Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 24

Genomic Vision Extends Agreement with Quest Diagnostics 24

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 25

Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 26

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 27

PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 28

Quest Diagnostics Enters Into Technology Integration Agreement With Appian 29

Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 30

Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 31

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 32

Vermillion Signs Agreement With Quest Diagnostics 33

Debt Offering 33

Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 33

Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 35

Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 36

Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 38

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 39

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 40

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 41

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 42

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 44

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 45

Asset Transactions 46

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 46

Acquisition 47

Quest Diagnostics May Sell itself 47

Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 48

Clinical Genomics Acquires Enterix From Quest Diagnostics 49

Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 49

Access Genetics Acquires OralDNA Labs From Quest Diagnostics 51

Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 52

Solstas Lab Partners Acquires NextWave Diagnostic Labs 53

Solstas Lab Partners Acquires Wilmington Pathology Lab 53

Solstas Lab Partners Acquires Select Diagnostics 54

Quest Diagnostics Completes Acquisition Of Celera 54

Quest Diagnostics Completes Acquisition Of Athena Diagnostics 57

Quest Diagnostics Inc-Key Competitors 59

Key Employees 60

Locations And Subsidiaries 62

Head Office 62

Other Locations & Subsidiaries 62

Recent Developments 65

Strategy And Business Planning 65

Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services 65

Financial Announcements 66

Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 66

Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 67

Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 68

Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 69

Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 71

Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 73

Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 74

Corporate Communications 75

Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 75

Legal and Regulatory 76

Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 76

Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation 77

Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation 78

Aug 18, 2016: Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services 79

Product News 80

Feb 16, 2017: Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care 80

Jun 01, 2016: One Year After Launch, BRCA Share Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk 81

May 26, 2016: Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk 83

Apr 15, 2016: New Diagnostic Pathways Could Improve Dementia Diagnosis, According to Consensus Statements to Be Presented at the American Academy of Neurology Annual Meeting 85

Apr 14, 2016: Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies 87

Feb 24, 2016: Quest Diagnostics and Inovalon Bring Real-Time, Point-of-Care Analytics to HIMSS16 with Data Diagnostics 88

Feb 22, 2016: Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum Brand 90

Other Significant Developments 92

Jan 18, 2017: Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy 92

Nov 21, 2016: Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri 93

Sep 13, 2016: Optum and Quest Diagnostics Partner to Help Make the Health System Work Better for Patients, Physicians, Health Plans and Employers 94

Aug 03, 2016: Quest Diagnostics and AncestryDNA Collaborate to Expand Consumer DNA Testing 95

Jul 13, 2016: Apollo Enters Agreement with ChartMaxx from Quest Diagnostics to Provide Enterprise Imaging and Content Management Technology 96

Jun 15, 2016: Quest Diagnostics and Safeway Team to Offer Convenient Diagnostic Testing to Customers in More States 97

May 31, 2016: Quest Diagnostics and HCA's HealthONE System Partner to Deliver High-Value and Innovative Laboratory Services at Six Denver-Area HealthONE Hospitals 98

Appendix 99

Methodology 99

About GlobalData 99

Contact Us 99

Disclaimer 99

List of Figures

Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 9

Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Quest Diagnostics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 11

List of Tables

Quest Diagnostics Inc, Medical Equipment, Key Facts, 2016 1

Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8

Quest Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9

Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10

Quest Diagnostics Inc, Deals By Market, 2011 to YTD 2017 11

Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12

Clinical Genomics Technologies Raises USD11.4 Million in Series A Financing Round 15

Vermillion Enters into Licensing Agreement with Quest Diagnostics 15

Clinical Genomics Enters into Licensing Agreement with CSIRO 16

Illumina Enters Into Licensing Agreement With Quest Diagnostics 17

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 18

Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 18

Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 19

Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 20

Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 21

Clinical Genomics Extends Its Licensing Agreement With Quest Diagnostics 22

Biocept to Form Partnership with Quest Diagnostics Mexico 22

DermTech Enters into Agreement with Dermpath Diagnostics 23

Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 24

Genomic Vision Extends Agreement with Quest Diagnostics 24

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 25

Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 26

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 27

PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 28

Quest Diagnostics Enters Into Technology Integration Agreement With Appian 29

Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 30

Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 31

RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 32

Vermillion Signs Agreement With Quest Diagnostics 33

Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 33

Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 35

Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 36

Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 38

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 39

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 40

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 41

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 42

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 44

Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 45

DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 46

Quest Diagnostics May Sell itself 47

Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 48

Clinical Genomics Acquires Enterix From Quest Diagnostics 49

Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 49

Access Genetics Acquires OralDNA Labs From Quest Diagnostics 51

Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 52

Solstas Lab Partners Acquires NextWave Diagnostic Labs 53

Solstas Lab Partners Acquires Wilmington Pathology Lab 53

Solstas Lab Partners Acquires Select Diagnostics 54

Quest Diagnostics Completes Acquisition Of Celera 54

Quest Diagnostics Completes Acquisition Of Athena Diagnostics 57

Quest Diagnostics Inc, Key Competitors 59

Quest Diagnostics Inc, Key Employees 60

Quest Diagnostics Inc, Subsidiaries 62

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Quest Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com